1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. North America Pharmaceutical Drug Delivery Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. North America Pharmaceutical Drug Delivery Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Increasing Prevalence of Chronic Diseases and Infectious Diseases
- 5.1.2 Increasing Demand for Non-Invasive Drug Delivery
5.2 Market Opportunities
- 5.2.1 Focus on Improving Patient Compliance
5.4 Impact of Drivers and Restraints
6. North America Pharmaceutical Drug Delivery Market Regional Analysis
6.1 North America Pharmaceutical Drug Delivery Market Overview
6.2 North America Pharmaceutical Drug Delivery Market Revenue 2017-2027 (US$ Million)
6.3 North America Pharmaceutical Drug Delivery Market Forecast Analysis
7. North America Pharmaceutical Drug Delivery Market Analysis – by Route of Administration
7.1 Oral Drug Delivery
- 7.1.1 Overview
- 7.1.2 Oral Drug Delivery: North America Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Injectable Drug Delivery
- 7.2.1 Overview
- 7.2.2 Injectable Drug Delivery: North America Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Topical Drug Delivery
- 7.3.1 Overview
- 7.3.2 Topical Drug Delivery: North America Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Ocular Drug Delivery
- 7.4.1 Overview
- 7.4.2 Ocular Drug Delivery: North America Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Pulmonary Drug Delivery
- 7.5.1 Overview
- 7.5.2 Pulmonary Drug Delivery: North America Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
7.6 Nasal Drug Delivery
- 7.6.1 Overview
- 7.6.2 Nasal Drug Delivery: North America Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
7.7 Transmucosal Drug Delivery
- 7.7.1 Overview
- 7.7.2 Transmucosal Drug Delivery: North America Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
7.8 Implantable Drug Delivery
- 7.8.1 Overview
- 7.8.2 Implantable Drug Delivery: North America Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
8. North America Pharmaceutical Drug Delivery Market Analysis – by Application
8.1 Infectious Diseases
- 8.1.1 Overview
- 8.1.2 Infectious Diseases: North America Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8.2 Cancer
- 8.2.1 Overview
- 8.2.2 Cancer: North America Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8.3 Cardiovascular Diseases
- 8.3.1 Overview
- 8.3.2 Cardiovascular Diseases: North America Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Diabetes
- 8.4.1 Overview
- 8.4.2 Diabetes: North America Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8.5 Respiratory Diseases
- 8.5.1 Overview
- 8.5.2 Respiratory Diseases: North America Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8.6 Central Nervous System Disorders
- 8.6.1 Overview
- 8.6.2 Central Nervous System Disorders: North America Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8.7 Autoimmune Diseases
- 8.7.1 Overview
- 8.7.2 Autoimmune Diseases: North America Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8.8 Other Diseases
- 8.8.1 Overview
- 8.8.2 Other Diseases: North America Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
9. North America Pharmaceutical Drug Delivery Market Analysis – by End User
9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Other Diseases: North America Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
9.2 Home Care Settings
- 9.2.1 Overview
- 9.2.2 Other Diseases: North America Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
9.3 ASC/Clinics
- 9.3.1 Overview
- 9.3.2 Other Diseases: North America Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
9.4 Other End Users
- 9.4.1 Overview
- 9.4.2 Other Diseases: North America Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
10. North America Pharmaceutical Drug Delivery Market – North America Analysis
10.1 North America
- 10.1.1 North America Pharmaceutical Drug Delivery Market Breakdown, by Key
Country, 2020 and 2027 (%)
- 10.1.1.1 North America Pharmaceutical Drug Delivery Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 US:
North America Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.1.1 US: North America Pharmaceutical Drug Delivery Market Breakdown, by Route of Administration
- 10.1.1.1.2 US: North America Pharmaceutical Drug Delivery Market Breakdown, by Application
- 10.1.1.1.3 US: North America Pharmaceutical Drug Delivery Market Breakdown, by End User
- 10.1.1.2 Canada:
North America Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.2.1 Canada: North America Pharmaceutical Drug Delivery Market Breakdown, by Route of Administration
- 10.1.1.2.2 Canada: North America Pharmaceutical Drug Delivery Market Breakdown, by Application
- 10.1.1.2.3 Canada: North America Pharmaceutical Drug Delivery Market Breakdown, by End User
- 10.1.1.3 Mexico :
North America Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.3.1 Mexico : North America Pharmaceutical Drug Delivery Market Breakdown, by Route of Administration
- 10.1.1.3.2 Mexico : North America Pharmaceutical Drug Delivery Market Breakdown, by Application
- 10.1.1.3.3 Mexico : North America Pharmaceutical Drug Delivery Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. North America Pharmaceutical Drug Delivery Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 3M
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Antares Pharma
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 BD
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Pfizer Inc.
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Johnson & Johnson Services, Inc.
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
14. Appendix
14.1 About Business Market Insights
Get Free Sample For North America Pharmaceutical Drug Delivery Market
